RxDoctor Payments Data

Mary Harding

Psychiatric/Mental Health · Mooresville, INNPI 1730722125

Payments from drug & device makers

$2,662in general payments, 2019–2025

Across 194 payments — averaging $13.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$427
  • AbbVie$296
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$291
  • Otsuka America Pharmaceutical, Inc.$287
  • Alkermes, Inc.$257
  • Axsome Therapeutics, Inc.$184
  • plus $919 from 14 others

What the payments were for

  • Food & beverage$2,60798%
  • Education$542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,662 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate17$169,275
RexultiBrexpiprazole23$73,334
VraylarCariprazine Hcl32$65,975
TrintellixVortioxetine Hydrobromide30$41,891
NuedextaDextromethorphan Hbr/Quinidine11$17,031
BelsomraSuvorexant35$14,825
Lurasidone Hcl28$13,299
Lamotrigine ErLamotrigine34$11,754
Aripiprazole119$10,917
DayvigoLemborexant22$7,497
Desvenlafaxine Succinate ErDesvenlafaxine Succinate50$6,858
Trazodone Hcl225$5,162
Duloxetine Hcl163$4,549
Methylphenidate Hcl Er (Cd)Methylphenidate Hcl11$3,466
Clonazepam479$3,105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$155$169,27517 claims
Otsuka America Pharmaceutical, Inc.Rexulti$287$73,33423 claims
AbbVieVraylar$296$65,97532 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$64$41,89130 claims
Almatica Pharma LLCSertraline Hcl$36$799113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Mooresville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →